Opportunities for Healthy Volunteers
Contribute to medical research by participating in studies designed for healthy participants in your selected area.
↓
Matched clinical trials
Study of belantamab mafodotin with drug combination for newly diagnosed multiple myeloma patients who cannot receive transplant
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of belantamab mafodotin combined with pomalidomide, dexamethasone, and daratumumab in patients with relapsed/refractory multiple myeloma who previously had 1-3 treatments and are lenalidomide resistant
Not recruiting
Investigated Diseases:Investigated Drugs:
Study on the Safety and Effects of Belantamab Mafodotin with Lenalidomide and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
Not recruiting
Investigated Diseases:Investigated Drugs:
Study Comparing Lenalidomide, Daratumumab, and Dexamethasone for Frail Patients with Untreated Multiple Myeloma Not Eligible for High-Dose Therapy
Not recruiting
Investigated Diseases:Investigated Drugs:


